Tech giant striving to beef up semiconductor solutions portfolio
Merck announced on Jan. 2 that it had finished the acquisition of M Chemicals, the company recently incorporated by Mecaro, to operate its chemical business.
The tech giant expected that the deal would complement a key segment of its semiconductor solutions portfolio while building on its localization efforts.
The closing of the transaction followed regulatory clearance and the fulfillment of other customary closing conditions, according to Merck.
The acquisition is projected to enable Merck to gain approximately 100 employees, as well as state-of-the-art production and research & development sites in Korea.
Merck noted that the contract was part of the “Level Up” growth program of Merck’s Electronics business sector.
The initiative includes investments of significantly more than 3 billion euros from 2021 to 2025 in innovation and capacities, focusing on four mutually reinforcing key priorities: scale, technology, portfolio, as well as capabilities.
“We’re delighted to announce our recent closing of the acquisition and continue expanding our regional capabilities in Korea, as well as our overall global capacity,” said Merck Senior Vice President Surésh Rajaraman, who leads the company’s thin-film solutions business.
“The acquisition of M Chemicals is another milestone in the expansion of our Electronics business and, in particular, Semiconductor Solutions, one of our ‘Big 3’ growth engines, through targeted smaller to medium-sized acquisitions with high impact.”
Founded in 1668, Merck operates in various areas like life science, healthcare, and electronics. With more than 60,000 employees, the outfit’s top line amounted to almost 20 billion euros in 2021.